Shubha Bhat

Shubha Bhat is a Clinical Pharmacy Specialist in the Digestive Disease Institute at the Cleveland Clinic. She earned her Doctor of Pharmacy degree from Northeastern University in Boston, Massachusetts. Following graduation, she completed a PGY1 pharmacy residency at Boston Medical Center, a PGY2 residency in Ambulatory Care at the University of Illinois at Chicago, and Health Outcomes Research Fellowship at the University of Colorado.
Dr. Bhat maintains an active clinical practice focused on optimizing medication therapy for patients with digestive diseases, including inflammatory bowel disease. Her responsibilities include delivering comprehensive medication eudcation, monitoring therapeutic outcomes, and advancing medication safety initiatives. In addition to her clinical work, Dr. Bhat is deeply committed to education and research. She actively precepts pharmacy trainees and leads research initatives centered on the impact of pharmacists on patient outcomes and optimziation of medication safety and access in inflammatory bowel disease.

Marina Ivanov, Pharm.D., BCACP, BCPS, is an Assistant Professor of Medicine at the Mayo Clinic College of Medicine and Science and an Inflammatory Bowel Disease Clinical Pharmacist Specialist at Mayo Clinic–Arizona. She is a clinical leader within a multidisciplinary IBD care team, practicing under a Collaborative Practice Agreement and specializing in the management of complex and severe IBD, with a focus on treat‑to‑target strategies and expanding patient access to advanced therapies. Dr. Ivanov plays a key role in graduate medical education as a residency program developer and preceptor and was recognized with the 2023 Joe L. Rogers Allied Health Teacher of the Year Award. Locally and nationally, she is actively engaged in advancing the role of pharmacists in IBD care, promoting their integration within IBD teams to enhance medication safety, and patient outcomes.

David T. Rubin is the Joseph B. Kirsner Professor of Medicine, Professor of Pathology, Chief of the Section of Gastroenterology, Hepatology & Nutrition and Director of the Inflammatory Bowel Disease Center at the University of Chicago Medicine. He earned a medical degree with honors at The University of Chicago Pritzker School of Medicine where he also completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics. He is associate faculty member at the MacLean Center for Clinical Medical Ethics, associate investigator at the University of Chicago Comprehensive Cancer Center and a member of the University of Chicago Committee on Clinical Pharmacology and Pharmacogenomics. He is the immediate past Chair of the National Scientific Advisory Committee of the Crohn’s & Colitis Foundation and Deputy Chair of the International Organization for the Study of IBD.
Dr. Rubin’s research is focused on disease modification in IBD including clinical trial designs, novel measures of inflammation and prevention of adverse outcomes, and quality of life in IBD. In 2023, he received both the UChicago Michael Reese Lectureship Award (for outstanding faculty who have developed novel teaching and clinical research that advances healthcare) and the distinguished UChicago Arthur H. Rubenstein Mentorship in Academic Medicine Award. Dr. Rubin is currently a senior editor of the 12 edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, and an author on >600 articles on management of IBD, including the 2019 and 2025 ACG Guidelines for ulcerative colitis.

David Choi completed his Doctor of Pharmacy degree at the University of Colorado School of Pharmacy. He went on to complete his PGY1 Pharmacy Residency and PGY2 Ambulatory residency at The Johns Hopkins Hospital. He is currently an Associate Director at University of Chicago Medicine Inflammatory Bowel Disease Center. He is very excited about advocating for increased pharmacists’ role in gastroenterology/hepatology as well as importance for patient advocacy in receiving the care they require. He feels passionately about treat to target to improve patient care and research related to improving patient outcomes.